Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 21-Dec-15 8:04 PM View:  | Tomasi Adam See Remarks | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition | 12,599 | $90.00 | $1,133,910.00 | (100%) 12.6K to 0 | |
| 21-Dec-15 6:38 PM View: | Alexander Robert Chief Executive Officer Director | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition | 30,750 | $90.00 | $2,767,500.00 | (100%) 30.75K to 0 | |
| 21-Dec-15 6:41 PM View: | Keyser D Jeffrey Chief Operating Officer | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition (change in control) | 216,169 | $90.00 | $19,455,200.00 | (100%) 216.17K to 0 | |
| 21-Dec-15 6:42 PM View: | Guillem Alvaro President | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition (change in control) | 186,923 | $90.00 | $16,823,100.00 | (100%) 186.92K to 0 | |
| 21-Dec-15 8:26 PM View: | Devon Park Bioventures Lp 10% Owner | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition (change in control) | 9,748 | $90.00 | $877,320.00 | (< 1%) 2.59M to 2.58M | |
| 21-Dec-15 6:44 PM View: | Akkaraju Srinivas Director | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition | 1,000 | $90.00 | $90,000.00 | (100%) 1.0K to 0 | |
| 21-Dec-15 6:42 PM View: | Asbury Mark Chief Legal Officer | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition | 6,921 | $90.00 | $622,890.00 | (100%) 6.92K to 0 | |
| 21-Dec-15 6:41 PM View: | Keyser D Jeffrey Chief Operating Officer | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition | 12,353 | $90.00 | $1,111,770.00 | (5%) 228.52K to 216.17K | |
| 21-Dec-15 6:42 PM View: | Guillem Alvaro President | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition | 15,654 | $90.00 | $1,408,860.00 | (8%) 202.58K to 186.92K | |
| 21-Dec-15 8:23 PM View: | Rasmussen Henrik S Md Chief Medical Officer | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition | 3,000 | $90.00 | $270,000.00 | (100%) 3.0K to 0 | |
| 21-Dec-15 8:26 PM View: | Devon Park Bioventures Lp 10% Owner | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition (change in control) | 2,576,720 | $90.00 | $231,904,992.00 | (100%) 2.58M to 0 | |
| 21-Dec-15 8:14 PM View: | Babler Martin Director | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition | 1,000 | $90.00 | $90,000.00 | (100%) 1.0K to 0 | |
| 21-Dec-15 8:09 PM View: | Popovits Kimberly J Director | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition | 1,000 | $90.00 | $90,000.00 | (100%) 1.0K to 0 | |
| 21-Dec-15 8:13 PM View: | Nohra Guy P Director | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition | 1,000 | $90.00 | $90,000.00 | (100%) 1.0K to 0 | |
| 21-Dec-15 6:46 PM View: | Smith Cynthia Chief Commercial Officer | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition | 12,598 | $90.00 | $1,133,820.00 | (100%) 12.6K to 0 | |
| 21-Dec-15 8:18 PM View: | Ostro Marc Director 10% Owner | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition | 1,000 | $90.00 | $90,000.00 | (100%) 1.0K to 0 | |
| 21-Dec-15 6:39 PM View: | Whiting John M Director | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition | 1,000 | $90.00 | $90,000.00 | (100%) 1.0K to 0 | |
| 11-Dec-15 11:25 AM View: | Guillem Alvaro President | Zs Pharma, Inc. (ZSPH) | 10-Dec-15 | Option Exercise | 9,154 | $10.92 | $100,000.00 | 5% 186.92K to 196.08K | |
| 11-Dec-15 2:23 PM View: | Keyser D Jeffrey Chief Operating Officer | Zs Pharma, Inc. (ZSPH) | 09-Dec-15 | Option Exercise | 9,154 | $10.92 | $100,000.00 | 4% 216.17K to 225.32K | |
| 10-Dec-15 9:23 PM View: | Smith Cynthia Chief Commercial Officer | Zs Pharma, Inc. (ZSPH) | 08-Dec-15 | Option Exercise | 9,155 | $10.92 | $100,011.00 | 100% 0 to 9.15K | |
| 10-Dec-15 7:27 PM View: | Tomasi Adam See Remarks | Zs Pharma, Inc. (ZSPH) | 08-Dec-15 | Option Exercise | 9,156 | $10.92 | $100,022.00 | 100% 0 to 9.16K | |
| 10-Dec-15 8:08 PM View: | Alexander Robert Chief Executive Officer Director | Zs Pharma, Inc. (ZSPH) | 08-Dec-15 | Option Exercise | 17,807 | $5.62 | $100,004.00 | 100% 0 to 17.81K | |
| 10-Dec-15 5:27 PM View: | Asbury Mark Chief Legal Officer | Zs Pharma, Inc. (ZSPH) | 08-Dec-15 | Option Exercise | 3,478 | $28.75 | $99,992.50 | 100% 0 to 3.48K | |
| 24-Aug-15 6:14 PM View: | Creech Todd A | Zs Pharma, Inc. (ZSPH) | 21-Aug-15 | Market Option Sale | 50,000 | $49.76 | $2,488,000.00 | (100%) 50.0K to 0 | (81%) |
| 24-Aug-15 6:14 PM View: | Creech Todd A | Zs Pharma, Inc. (ZSPH) | 21-Aug-15 | Option Exercise | 50,000 | $2.13 | $106,500.00 | 100% 0 to 50.0K | |
| 24-Aug-15 6:14 PM View: | Creech Todd A | Zs Pharma, Inc. (ZSPH) | 20-Aug-15 | Option Exercise | 20,000 | $2.13 | $42,600.00 | 100% 0 to 20.0K | |
| 24-Aug-15 6:14 PM View: | Creech Todd A | Zs Pharma, Inc. (ZSPH) | 20-Aug-15 | Market Option Sale | 20,000 | $50.03 | $1,000,600.00 | (100%) 20.0K to 0 | (80%) |
| 09-Jun-15 4:12 PM View: | Alta Partners Viii, L.P. 10% Owner | Zs Pharma, Inc. (ZSPH) | 08-Jun-15 | Market Sale | 11,200 | $57.53 | $644,336.00 | (< 1%) 2.66M to 2.65M | (56%) |
| 09-Jun-15 4:12 PM View: | Alta Partners Viii, L.P. 10% Owner | Zs Pharma, Inc. (ZSPH) | 05-Jun-15 | Market Sale | 164,227 | $57.88 | $9,505,460.00 | (6%) 2.82M to 2.66M | (55%) |
| 05-Jun-15 5:25 PM View: | Alta Partners Viii, L.P. 10% Owner | Zs Pharma, Inc. (ZSPH) | 04-Jun-15 | Market Sale | 88,408 | $57.49 | $5,082,280.00 | (3%) 2.91M to 2.82M | (56%) |
| 05-Jun-15 5:25 PM View: | Alta Partners Viii, L.P. 10% Owner | Zs Pharma, Inc. (ZSPH) | 03-Jun-15 | Market Sale | 23,189 | $56.60 | $1,312,500.00 | (< 1%) 2.93M to 2.91M | (59%) |
| 02-Jun-15 7:54 PM View: | Alta Partners Viii, L.P. 10% Owner | Zs Pharma, Inc. (ZSPH) | 02-Jun-15 | Market Sale | 84,342 | $56.77 | $4,788,100.00 | (3%) 3.02M to 2.93M | (58%) |
| 02-Jun-15 7:54 PM View: | Alta Partners Viii, L.P. 10% Owner | Zs Pharma, Inc. (ZSPH) | 01-Jun-15 | Market Sale | 72,520 | $58.00 | $4,206,160.00 | (2%) 3.09M to 3.02M | (55%) |
| 02-Jun-15 7:54 PM View: | Alta Partners Viii, L.P. 10% Owner | Zs Pharma, Inc. (ZSPH) | 29-May-15 | Market Sale | 139,561 | $58.74 | $8,198,040.00 | (4%) 3.23M to 3.09M | (53%) |
| 17-Dec-14 4:27 PM View: | 3x5 Special Opportunity Fun... 10% Owner | Zs Pharma, Inc. (ZSPH) | 15-Dec-14 | Disposition (other) | 365,354 | -- | -- | (64%) 568.04K to 202.69K | |
| 17-Dec-14 4:27 PM View: | 3x5 Special Opportunity Fun... 10% Owner | Zs Pharma, Inc. (ZSPH) | 15-Dec-14 | Market Sale | 79,444 | $47.09 | $3,741,340.00 | (39%) 202.69K to 123.25K | (91%) |
| 25-Jun-14 11:30 AM View: | Nohra Guy P Director | Zs Pharma, Inc. (ZSPH) | 23-Jun-14 | Purchase Duplicate | 200,000 | $18.00 | $3,600,000.00 | 7% 3.03M to 3.23M | |
| 25-Jun-14 11:38 AM View: | Keyser D Jeffrey Chief Operating Officer Director | Zs Pharma, Inc. (ZSPH) | 23-Jun-14 | Conversion | 48,744 | -- | -- | 29% 167.43K to 216.17K | |
| 25-Jun-14 7:30 PM View: | Ostro Marc Director 10% Owner | Zs Pharma, Inc. (ZSPH) | 23-Jun-14 | Purchase Duplicate | 160,000 | $18.00 | $2,880,000.00 | 7% 2.44M to 2.6M | |
| 25-Jun-14 11:30 AM View: | Nohra Guy P Director | Zs Pharma, Inc. (ZSPH) | 23-Jun-14 | Conversion Duplicate | 3,030,090 | -- | -- | 100% 0 to 3.03M | |
| 25-Jun-14 11:37 AM View: | Alta Partners Viii, L.P. 10% Owner | Zs Pharma, Inc. (ZSPH) | 23-Jun-14 | Conversion | 3,030,090 | -- | -- | 100% 0 to 3.03M | |
| 25-Jun-14 11:23 AM View: | Guillem Alvaro President Director | Zs Pharma, Inc. (ZSPH) | 23-Jun-14 | Conversion | 21,191 | -- | -- | 13% 165.73K to 186.92K | |
| 24-Jun-14 4:34 PM View: | Novo A/s 10% Owner | Zs Pharma, Inc. (ZSPH) | 23-Jun-14 | Conversion | 506,730 | -- | -- | 100% 0 to 506.73K | |
| 25-Jun-14 7:30 PM View: | Devon Park Bioventures Lp 10% Owner | Zs Pharma, Inc. (ZSPH) | 23-Jun-14 | Conversion | 2,416,720 | -- | -- | 12396% 19.5K to 2.44M | |
| 25-Jun-14 11:37 AM View: | Alta Partners Viii, L.P. 10% Owner | Zs Pharma, Inc. (ZSPH) | 23-Jun-14 | Purchase | 200,000 | $18.00 | $3,600,000.00 | 7% 3.03M to 3.23M | |
| 25-Jun-14 11:38 AM View: | Keyser D Jeffrey Chief Operating Officer Director | Zs Pharma, Inc. (ZSPH) | 23-Jun-14 | Conversion | 21,191 | -- | -- | 14% 146.23K to 167.43K | |
| 24-Jun-14 4:34 PM View: | Novo A/s 10% Owner | Zs Pharma, Inc. (ZSPH) | 23-Jun-14 | Purchase | 275,000 | $18.00 | $4,950,000.00 | 54% 506.73K to 781.73K | |
| 25-Jun-14 7:30 PM View: | Ostro Marc Director 10% Owner | Zs Pharma, Inc. (ZSPH) | 23-Jun-14 | Conversion Duplicate | 2,416,720 | -- | -- | 12396% 19.5K to 2.44M | |
| 25-Jun-14 7:30 PM View: | Devon Park Bioventures Lp 10% Owner | Zs Pharma, Inc. (ZSPH) | 23-Jun-14 | Purchase | 160,000 | $18.00 | $2,880,000.00 | 7% 2.44M to 2.6M |
